Ep193: Ron Renaud on Helping People Lose Weight With GLP-1 Medicines
The Long Run with Luke Timmerman
00:00
The GLP‑1 obesity moment
Luke and Ron discuss the 2024 inflection as Lilly and Novo proved weight‑loss benefits and comorbidity reductions.
Play episode from 09:56
Transcript
